Dabigatran vs Erlotinib

Dabigatran vs Erlotinib: Overview

This comparison examines the pharmacological differences between Dabigatran and Erlotinib.

Mechanism of Action

Dabigatran: Direct thrombin (Factor IIa) inhibitor.

Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

Pharmacokinetics

Half-life: Dabigatran — 12-17 hours; Erlotinib — 36 hours.

Chemical Properties

Molecular Formula: Dabigatran — C25H25N7O3; Erlotinib — C22H23N3O4.

Molecular Weight: Dabigatran — 471.5100 g/mol; Erlotinib — 393.4380 g/mol.

Type: Dabigatran — Small molecule; Erlotinib — Small molecule.